Evaluation of Port Delivery System with ranibizumab for the treatment of neovascular age-related macular degeneration
| Autor: | Nika Bagheri, Dante J. Pieramici, Annika J Patel |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
genetic structures Visual Acuity Pharmaceutical Science Angiogenesis Inhibitors 03 medical and health sciences Macular Degeneration 0302 clinical medicine Port (medical) Age related Ophthalmology Ranibizumab medicine Humans 030304 developmental biology Anti vegf 0303 health sciences business.industry Macular degeneration medicine.disease eye diseases Treatment Outcome Intravitreal Injections 030221 ophthalmology & optometry sense organs Delivery system business medicine.drug |
| Zdroj: | Therapeutic delivery. 12(3) |
| ISSN: | 2041-6008 |
| Popis: | Current treatment of neovascular age-related macular degeneration involves periodic intravitreal injections of anti-VEGF medication, creating a burden to patients and physicians, resulting in nonadherence to recommended dosing schedules. The Port Delivery System with ranibizumab offers a long-term solution that involves implantation of a device into the pars plana and provides continuous release of anti-VEGF medication into the vitreous, thus requiring fewer office visits. The Port Delivery System has demonstrated comparable visual and anatomic outcomes to monthly injections and shows promise in alleviating the patient burden in the treatment of neovascular age-related macular degeneration, making possible better long-term real-world visual outcomes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|